This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veterinary Therapeutic Protein and Peptide Formulation, Manufacturing and Quality Control
BioVenic offers a comprehensive range of services tailored to meet the specific formulation needs of veterinary therapeutic protein and peptide drugs for preclinical research. Our expertise encompasses injectable formulations, inhalable systems, nanoparticle formulations, and more, ensuring that each solution is designed to maximize the therapeutic potential of these complex molecules. In addition to innovative formulation solutions, we provide full-scale manufacturing and rigorous quality control, guaranteeing consistent, high-quality production from start to finish. This integrated approach ensures that our clients receive not only effective formulations but also reliable, scalable production solutions.
Overview
BioVenic focuses on developing and refining veterinary therapeutic proteins and peptides during the preclinical research phase. Our services include creating stable and effective formulations, scalable manufacturing, and thorough quality control to ensure consistency, purity, and safety. By supporting preclinical studies with reliable formulations and data, we help set the stage for a smooth transition to clinical trials, ensuring the most promising candidates move forward in development for animal use.
Fig.1 The overview of veterinary therapeutic protein and peptide formulation, manufacturing, and quality control. (BioVenic Original)
Veterinary Therapeutic Protein and Peptide Formulation Development
BioVenic offers a suite of tailored services for the development of veterinary therapeutic proteins and peptides, focusing on customized formulation design, stability enhancement, and efficacy improvement, as well as the development of advanced delivery systems to satisfy the unique demands of veterinary medicine.
-
Injectable Formulations
We excel in developing injectable veterinary formulations, including solutions, suspensions, and emulsions, with a focus on stability, compatibility, and controlled release for optimal therapeutic efficacy. -
Oral Formulations
Our expertise lies in crafting oral formulations such as tablets, capsules, and nanoparticles, prioritizing bioavailability and protection against enzymatic degradation to meet client-specific requirements. -
Topical and Transdermal Formulations
We specialize in creating topical and transdermal peptide and protein formulations for effective penetration and precise targeting of therapeutic agents. -
Inhalation Formulations
Our know-how includes the development of inhalable peptide and protein formulations for targeted respiratory delivery, utilizing dry powder inhalers or nebulizers for efficient preclinical treatment. -
Implantable Formulations
We also offer advanced solutions for implantable peptide and protein formulations. These are designed to provide sustained release and localized delivery, ensuring long-term therapeutic effects where needed. -
Liposomal and Nanoparticle Formulations
Our capabilities include formulating veterinary therapeutic peptides and proteins into liposomes or nanoparticles. This enhances their stability and bioavailability, enabling targeted delivery to specific tissues or cellular targets. -
Combination Formulations
We are proficient in developing combination formulations that integrate peptides or proteins with other active compounds or therapeutic strategies. This approach is aimed at achieving synergistic effects and optimizing therapeutic outcomes.
Protein and Peptide Manufacturing Development
Veterinary therapeutic protein and peptide manufacturing is a complex and time-consuming process. Protein and peptide manufacturing services are vital for the development of innovative therapeutics, driven by advancements in biotechnology and genetic engineering. These services include solid-phase and solution-phase synthesis for peptides and recombinant DNA (rDNA) technology for proteins, enabling scalable production of complex molecules. With the increasing demand for biologics and biopharmaceuticals, such services focus on optimizing yield, ensuring purity, and meeting stringent regulatory standards. BioVenic offers manufacturing techniques that support the development of therapies targeting various animal diseases during preclinical research, offering high specificity, potency, and reduced toxicity.
Protein and Peptide Quality Control
BioVenic provides comprehensive quality control services for veterinary therapeutic proteins and peptides, tailored to meet the unique needs of our clients. Leveraging our deep expertise in biologics analysis and formulation development for complex products, we accelerate your development process by generating precise data and submitting detailed reports. Dedicated to bringing quality and safety to life, we employ our total quality assurance approach to help your biologic development programs not only meet but exceed stringent quality, safety, and regulatory standards. Our quality control service includes appearance, solubility, identity, amino acid composition and chiral purity, related substances, counterion content, moisture content, mass balance, residual trifluoroacetic acid, and among others.
Service Workflow
Our service begins with a consultation to thoroughly understand the client's needs, and project objectives, and to define the scope of work. Following this, we design a customized formulation, manufacturing, and quality control strategy, which includes selecting the appropriate excipients, stabilizers, and delivery systems, and establishing the manufacturing process and quality control standards. The project then moves into execution, where we carry out the formulation and manufacturing process according to the designed plan, making necessary optimizations to meet the desired specifications. During the manufacturing and quality control phase, we ensure that the process is conducted in a controlled environment with rigorous quality testing to guarantee that the product meets all predefined standards for purity, potency, and stability. Finally, we deliver the formulated therapeutic protein or peptide product, accompanied by a comprehensive report detailing the manufacturing process, quality control results, and recommendations for further development.
Fig.2 The veterinary therapeutic protein and peptide formulation, manufacturing, and quality control service workflow. (BioVenic Original)
Why Choose Us?
Comprehensive One-Stop Service
BioVenic offers a comprehensive one-stop service for veterinary therapeutic proteins and peptides, covering every stage from initial formulation to final manufacturing and stringent quality control.
Tailored Route Design
By grasping the distinct challenges of each project, we tailor efficient solutions to address specific demands, such as stability and bioavailability, aligning every process step with your goals.
Extensive Industry Experience
With years of extensive experience in the field of veterinary therapeutic proteins and peptides, BioVenic combines scientific expertise with practical know-how.
Scalable and Efficient Batch Manufacturing
Our approach ensures consistency, cost-effectiveness, and adherence to the highest quality standards, providing clients with the flexibility to scale production as needed while maintaining product integrity.
With our comprehensive one-stop service, tailored route design, extensive industry experience, and scalable batch manufacturing capabilities, BioVenic is fully equipped to meet all your veterinary therapeutic protein and peptide needs. We invite you to explore how our expertise can support your next project. Contact us today to discuss your specific requirements and to receive a customized quote tailored to your project's goals and scale. Let us partner with you in delivering the highest quality veterinary therapeutic solutions.